Package 51662-1548-1

Brand: verapamil hci

Generic: verapamil hci
NDC Package

Package Facts

Identity

Package NDC 51662-1548-1
Digits Only 5166215481
Product NDC 51662-1548
Product ID 51662-1548_df7a677c-e654-5f4b-e053-2995a90a06b3
Description

4 mL in 1 VIAL, SINGLE-DOSE (51662-1548-1)

Marketing

Marketing Status
Marketed Since 2022-05-20
Brand verapamil hci
Generic verapamil hci
Sample Package No

Linked Drug Pages (1)

VERAPAMIL HCI ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "df7a677c-e654-5f4b-e053-2995a90a06b3", "openfda": {"upc": ["0355150343010"], "unii": ["V3888OEY5R"], "rxcui": ["1665061"], "spl_set_id": ["df786377-7d2c-249b-e053-2a95a90aab22"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "4 mL in 1 VIAL, SINGLE-DOSE (51662-1548-1)", "package_ndc": "51662-1548-1", "marketing_start_date": "20220520"}], "brand_name": "VERAPAMIL HCI", "product_id": "51662-1548_df7a677c-e654-5f4b-e053-2995a90a06b3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1548", "generic_name": "VERAPAMIL HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HCI", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA212965", "marketing_category": "ANDA", "marketing_start_date": "20220520", "listing_expiration_date": "20261231"}